The dawn phenomenon in type 2 diabetes: its association with glucose excursions and changes after oral glucose-lowering drugs.

Jun-Sing WangI-Te LeeWen-Jane LeeShi-Dou LinShih-Li SuShih-Te TuShih-Yi LinWayne Huey-Herng Sheu

Published in: Therapeutic advances in chronic disease (2021)

Glucose excursions were independently associated with the dawn phenomenon in patients with T2D on metformin monotherapy. Both glucose excursions and the dawn phenomenon improved after treatment with acarbose, but not after treatment with glibenclamide.

Keyphrases

type diabetes
blood glucose
cardiovascular disease
glycemic control
blood pressure
randomized controlled trial
adipose tissue
combination therapy
drug induced